IP Verse

Suppression Of Cancer - EP2664343

The patent EP2664343 was granted to Ipsen Bioinnovation on Dec 18, 2019. The application was originally filed on Nov 17, 2009 under application number EP13167699A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2664343

IPSEN BIOINNOVATION
Application Number
EP13167699A
Filing Date
Nov 17, 2009
Status
Patent Maintained As Amended
Nov 15, 2019
Grant Date
Dec 18, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ALLERGANDec 28, 2017HOFFMANN EITLEADMISSIBLE

Patent Citations (104) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS19880282328-
DESCRIPTIONUS19890317941-
DESCRIPTIONUS19890376555-
DESCRIPTIONUS19890394727-
DESCRIPTIONUS19890440039-
DESCRIPTIONUS19900502438-
DESCRIPTIONUS19900520225-
DESCRIPTIONEP0030920
DESCRIPTIONEP0171477
DESCRIPTIONEP0257742
DESCRIPTIONEP0329295
DESCRIPTIONEP0363589
DESCRIPTIONEP0389180
DESCRIPTIONEP0395417
DESCRIPTIONEP0505680
DESCRIPTIONEP0737891
DESCRIPTIONFR2522655
DESCRIPTIONUS2002098178
DESCRIPTIONUS2007166332
DESCRIPTIONUS4133782
DESCRIPTIONUS4148612
DESCRIPTIONUS4190575
DESCRIPTIONUS4190648
DESCRIPTIONUS4211693
DESCRIPTIONUS4235886
DESCRIPTIONUS4238481
DESCRIPTIONUS4261885
DESCRIPTIONUS4282143
DESCRIPTIONUS4291022
DESCRIPTIONUS4310518
DESCRIPTIONUS4316890
DESCRIPTIONUS4328214
DESCRIPTIONUS4360516
DESCRIPTIONUS4369179
DESCRIPTIONUS4522813
DESCRIPTIONUS4585755
DESCRIPTIONUS4603120
DESCRIPTIONUS4650787
DESCRIPTIONUS4659693
DESCRIPTIONUS4684620
DESCRIPTIONUS4725577
DESCRIPTIONUS4853371
DESCRIPTIONUS4871717
DESCRIPTIONUS4904642
DESCRIPTIONUS5223409
DESCRIPTIONUS5240561
DESCRIPTIONUS5506339
DESCRIPTIONUS5550212
DESCRIPTIONUS5552520
DESCRIPTIONUS5942489
DESCRIPTIONUS6057422
DESCRIPTIONWO0004926
DESCRIPTIONWO0010598
DESCRIPTIONWO0061192
DESCRIPTIONWO0062814
DESCRIPTIONWO0075186
DESCRIPTIONWO0121213
DESCRIPTIONWO2006059093
DESCRIPTIONWO2007104567
DESCRIPTIONWO2008008803
DESCRIPTIONWO2008008805
DESCRIPTIONWO8802756
DESCRIPTIONWO8902897
DESCRIPTIONWO9003980
DESCRIPTIONWO9012811
DESCRIPTIONWO9102746
DESCRIPTIONWO9105563
DESCRIPTIONWO9116923
DESCRIPTIONWO9117181
DESCRIPTIONWO9118016
DESCRIPTIONWO9206204
DESCRIPTIONWO9213883
DESCRIPTIONWO9220363
DESCRIPTIONWO9222322
DESCRIPTIONWO9315766
DESCRIPTIONWO9411396
DESCRIPTIONWO9411397
DESCRIPTIONWO9421300
DESCRIPTIONWO9616707
DESCRIPTIONWO9622782
DESCRIPTIONWO9632126
DESCRIPTIONWO9633273
DESCRIPTIONWO9633729
DESCRIPTIONWO9701579
DESCRIPTIONWO9807864
DESCRIPTIONWO9808528
DESCRIPTIONWO9808529
DESCRIPTIONWO9958571
DESCRIPTIONWO9958769
OPPOSITIONWO0010598
OPPOSITIONWO0121213
OPPOSITIONWO2009150469
OPPOSITIONWO2009150470
OPPOSITIONWO2010055358
OPPOSITIONWO2011020115
SEARCHUS2005031648
SEARCHUS2008161543
SEARCHWO0209743
SEARCHWO2004076634
SEARCHWO2006026780
SEARCHWO2006094539
SEARCHWO2008105901
SEARCHWO2009150469
SEARCHWO2009150470

Non-Patent Literature (NPL) Citations (107) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ALTSCHUL ET AL., BULL. MATH. BIO., (1986), vol. 48, pages 603 - 16-
DESCRIPTION- AUMELAS ET AL., INT. J. PEPTIDE RES., (1987), vol. 30, page 596-
DESCRIPTION- BLANKE ET AL., PROC. NATL. ACAD. SCI. USA, (1996), vol. 93, pages 8437 - 8442-
DESCRIPTION- BLAUSTEIN, FEBS LETTS, (1987), vol. 226, no. 1, pages 115 - 120-
DESCRIPTION- BOWIE; SAUER, PROC. NATL. ACAD. SCI. USA, (1989), vol. 86, pages 2152 - 6-
DESCRIPTION- CARANIKAS ET AL., J. MED. CHEM., (1982), vol. 25, page 1313-
DESCRIPTION- C. E. LAWRENCE ET AL., "Detecting Subtle Sequence Signals: A Gibbs Sampling Strategy for Multiple Alignment", SCIENCE, (1993), vol. 262, no. 5131, pages 208 - 214-
DESCRIPTION- CHUNG ET AL., PROC. NATL. ACAD. SCI. USA, (1993), vol. 90, pages 10145 - 9-
DESCRIPTION- CHUNG ET AL., SCIENCE, (1993), vol. 259, pages 806 - 9-
DESCRIPTION- CUNNINGHAM; WELLS, SCIENCE, (1989), vol. 244, pages 1081 - 5-
DESCRIPTION- CUTTITTA ET AL., CANCER SURVEYS, (1985), vol. 4, page 707-
DESCRIPTION- DERBYSHIRE ET AL., GENE, (1986), vol. 46, page 145-
DESCRIPTION- DE VOS ET AL., SCIENCE, (1992), vol. 255, pages 306 - 12-
DESCRIPTION- DINEEN ET AL., "The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer", BMC CANCER, (2008), vol. 8, page 352-
DESCRIPTION- DUBREUIL ET AL., Drug Design and Delivery, HARWOOD ACADEMIC PUBLISHERS, (1987), vol. 2, page 49-
DESCRIPTION- ELLMAN ET AL., METHODS ENZYMOL., (1991), vol. 202, page 301-
DESCRIPTION- ENGBERG ET AL., NATURE, (1984), vol. 293, page 222-
DESCRIPTION- ERIC DEPIEREUX; ERNEST FEYTMANS, "Match-Box: A Fundamentally New Algorithm for the Simultaneous Alignment of Several Protein Sequences", CABIOS, (1992), vol. 8, no. 5, pages 501 - 509-
DESCRIPTION- GARGOSKY ET AL., BIOCHERN. J., (1987), vol. 247, page 427-
DESCRIPTION- HALPERN J, J. BIOL. CHEM., (1993), vol. 268, no. 15, pages 11188 - 11192-
DESCRIPTION- HEIKKILA ET AL., J. BIOL. CHEM., (1987), vol. 262, page 16456-
DESCRIPTION- HEINZ-ERIAN ET AL., AM. J. PHYSIOL., (1986), page G439-
DESCRIPTION- HENIKOFF; HENIKOFF, PROC. NATL. ACAD. SCI. USA, (1992), vol. 89, pages 10915 - 19-
DESCRIPTION- HERREROS J, BIOCHEM. J., (2000), vol. 347, pages 199 - 204-
DESCRIPTION- IVO VAN WALLE ET AL., "Align-M - A New Algorithm for Multiple Alignment of Highly Divergent Sequences", BIOINFORMATICS, (2004), vol. 20, no. 9, pages 1428 - 1435-
DESCRIPTION- JULIE D. THOMPSON ET AL., "CLUSTAL W: Improving the Sensitivity of Progressive Multiple Sequence Alignment Through Sequence Weighting, Position- Specific Gap Penalties and Weight Matrix Choice", NUCLEIC ACIDS RESEARCH, (1994), vol. 22, no. 22, pages 4673 - 4680-
DESCRIPTION- KNAPP, AM. CRYST. ASSOC. ABSTRACT PAPERS, (1998), vol. 25, page 90-
DESCRIPTION- KOIDE ET AL., BIOCHEM., (1994), vol. 33, pages 7470 - 6-
DESCRIPTION- LACEY DB, NAT. STRUCT. BIOL., (1998), vol. 5, pages 898 - 902-
DESCRIPTION- LEANDER ET AL., NATURE, (1981), vol. 294, page 467-
DESCRIPTION- LONDON, E., BIOCHEM. BIOPHYS. ACTA., (1992), vol. 1112, pages 25 - 51-
DESCRIPTION- LOWMAN ET AL., BIOCHEM., (1991), vol. 30, pages 10832 - 7-
DESCRIPTION- LUNDBERG ET AL., PROC. NAT, ACA. SCI., (1983), vol. 80, page 1120-
DESCRIPTION- MARTINEZ ET AL., J. MED. CHEM., (1985), vol. 28, page 1874-
DESCRIPTION- Methods in Enzymology Vol 220 and 221, Membrane Fusion Techniques, Parts A and B, ACADEMIC PRESS, (1993), vol. 220, 221-
DESCRIPTION- MIZRAHI ET AL., EURO. J. PHARMA., (1982), vol. 82, page 101-
DESCRIPTION- MURATA ET AL., BIOCHEM., (1992), vol. 31, pages 1986 - 1992-
DESCRIPTION- NAGY ET AL., PNAS, (1998), vol. 95, pages 1794 - 99-
DESCRIPTION- NER ET AL., DNA, (1988), vol. 7, page 127-
DESCRIPTION- NORD, K. ET AL., "Binding proteins selected from combinatorial libraries of an alpha-helical bacterial receptor domain", NAT BIOTECHNOL, (1997), vol. 15, pages 772 - 777-
DESCRIPTION- O=KEEFE ET AL., PROC. NATL. ACAD. SCI. USA, (1992), vol. 89, pages 6202 - 6206-
DESCRIPTION- OSAMU GOTOH, "Significant Improvement in Accuracy of Multiple Protein. Sequence Arguments by Iterative Refinement as Assessed by Reference to Structural Alignments", J. MOL. BIOL., (1996), vol. 264, no. 4, pages 823 - 838-
DESCRIPTION- PLANK ET AL., J. BIOL. CHEM., (1994), vol. 269, pages 12918 - 12924-
DESCRIPTION- PRIOR ET AL., BIOCHEMISTRY, (1992), vol. 31, pages 3555 - 3559-
DESCRIPTION- "Receptor-binding studies, a brief outline", HULME, E.C., Receptor biochemistry, A Practical Approach, OXFORD UNIVERSITY PRESS, (1990), pages 303 - 311-
DESCRIPTION- REIDHAAR-OLSON; SAUER, SCIENCE, (1988), vol. 241, pages 53 - 7-
DESCRIPTION- RIVIER ET AL., BIOCHEM., (1978), vol. 17, page 1766-
DESCRIPTION- ROBERTSON ET AL., J. AM. CHEM. SOC., (1991), vol. 113, page 2722-
DESCRIPTION- ROSELL ET AL., TRENDS IN PHARMACOLOGICAL SCIENCES, (1982), vol. 3, page 211-
DESCRIPTION- RUMMEL A, MOL. MICROBIOL., (2004), vol. 51, no. 3, pages 631 - 643-
DESCRIPTION- RUMMEL A, PNAS, (2007), vol. 104, pages 359 - 364-
DESCRIPTION- RUMMEL ET AL., MOLECULAR MICROBIOL., (2004), vol. 51, pages 631 - 634-
DESCRIPTION- SAEED ET AL., PEPTIDES, (1989), vol. 10, page 597-
DESCRIPTION- SHONE C., EUR. J. BIOCHEM, (1987), vol. 167, no. 1, pages 175 - 180-
DESCRIPTION- SHONE ET AL., EUR. J. BIOCHEM., (1985), vol. 151, pages 75 - 82-
DESCRIPTION- SILVERMAN ET AL., J. BIOL. CHEM., (1993), vol. 269, pages 22524 - 22532-
DESCRIPTION- SILVERMAN ET AL., "Multivalent avimer proteins evolved by exon shuffling of a family of human receptor domains", NAT BIOTECHNOL, (2005), vol. 23, pages 1556 - 61-
DESCRIPTION- SKERRA, "Alternative binding proteins: anticalins - harnessing the structural plasticity of the lipocalin ligand pocket to engineer novel binding activities", FEBS J., (2008), vol. 275, pages 2677 - 83-
DESCRIPTION- SMITH ET AL., J. MOL. BIOL., (1992), vol. 224, pages 899 - 904-
DESCRIPTION- SWAMINATHAN; ESWARAMOORTHY, NAT. STRUCT. BIOL., (2000), vol. 7, pages 1751 - 1759-
DESCRIPTION- "Synthetic Peptides: Approaches to Biological Problems", HEIMBROOK ET AL., UCLA Symposium on Mol. and Cell. Biol. New Series, vol. 86-
DESCRIPTION- TURCATTI ET AL., J. BIOL. CHEM., (1996), vol. 271, pages 19991 - 8-
DESCRIPTION- UMLAND TC, NAT. STRUCT. BIOL., (1997), vol. 4, pages 788 - 792-
DESCRIPTION- VAN BINST, G. ET AL., PEPTIDE RESEARCH, (1992), vol. 5, page 8-
DESCRIPTION- WAGNER ET AL., PNAS, (1992), vol. 89, pages 7934 - 7938-
DESCRIPTION- WLODAVER ET AL., FEBS LETT., (1992), vol. 309, pages 59 - 64-
DESCRIPTION- WOLL ET AL., BIOCHEM. BIOPHYS. RES. COMM., (1988), vol. 155, page 359-
DESCRIPTION- WYNN; RICHARDS, PROTEIN SCI., (1993), vol. 2, pages 395 - 403-
DESCRIPTION- YU ET AL., PEPTIDES, (2006), vol. 27, no. 6, pages 1359 - 66-
DESCRIPTION- ZACHARY ET AL., PROC. NAT. ACA. SCI., (1985), vol. 82, page 7616-
DESCRIPTION- ZAHND ET AL., "Selection and characterization of Her2 binding-designed ankyrin repeat proteins", J BIOL CHEM., (2006), vol. 281, pages 35167 - 75-
OPPOSITION- Anonymous, "Gastrinoma", Wikipedia, the free encyclopedia, (20171030), XP055447673-
OPPOSITION- GRAFF et al., "Expression of vesicular monoamine transporters, synaptosomal-associated protein 25 and syntaxin1: A signature of human small cell lung carcinoma", Cancer Research, (20010301), vol. 615, pages 2138 - 2144, XP002493134-
OPPOSITION- HALPERN J, "Characterization of the receptor-binding domain of tetanus toxin", J. Biol. Chem., (19930525), vol. 268, no. 15, pages 11188 - 11192, XP002151795-
OPPOSITION- HANAHAN, D. et al., "The Hallmarks of Cancer", Cell, (20000107), vol. 100, no. 1, pages 57 - 70, XP055447752-
OPPOSITION- HUA, S. et al., "Activity-dependent changes in partial VAM P complexes during neurotransmitter release", Nature Neuroscience, (19990000), vol. 2, no. 12, pages 1078 - 1083, XP055447772-
OPPOSITION- Ingenuity Data CXCR4-
OPPOSITION- Ingenuity Data EGFR-
OPPOSITION- Ingenuity Data GHR-
OPPOSITION- Ingenuity Data GRP-
OPPOSITION- Ingenuity Data IGF1R-
OPPOSITION- Ingenuity Data NMBR-
OPPOSITION- Ingenuity Data SSTR1-
OPPOSITION- Ingenuity Data SSTR2-
OPPOSITION- Ingenuity Data SSTR3-
OPPOSITION- WEIMBS et al., "A model for structural similarity between different SNARE complexes based on sequence relationships", trends in Cell Biology, (19980700), vol. 8, pages 260 - 262, XP055447776-
OPPOSITION- HAYASHI et al., "Synaptic vesicle membrane fusion complex: action of clostridial neurotoxins on assembly", EMBO J., (19941101), vol. 13, no. 21, pages 5051 - 5061, XP055447822
OPPOSITION- LU et al., "Heterogeneous expression of SNARE proteins SNAP-23, SNAP-25, Syntaxin1 and VAMP in human parathyroid tissue", Mol Cell Endocrinol, (20080611), vol. 287, no. 1-2, pages 72 - 80, XP022671887
OPPOSITION- GHEZZO A et al., "Neuropsycological gender differences in healthy individuals and in pediatric neurodevelopmental disorders. A role for SNAP-25", Med Hypotheses, (20091201), vol. 73, no. 6, pages 978 - 980, XP026775106
OPPOSITION- BLOKHINA et al., "027046565Oxidative metabolism, ROS and NO under oxygen deprivation", Plant Physiol Biochem, (20100500), vol. 48, no. 5, pages 359 - 373, XP027046565
OPPOSITION- MERCURIO et al., "Autocrine signaling in carcinoma: VEGF and the α6β4 integrin", Seminars in Cancer Biology, (20040000), vol. 14, pages 115 - 122, XP055447661
OPPOSITION- TORREJON-ESCRIBANO et al., "SNARE expression and distribution during 3T3-L1 adipocyte differentiation", FEBS Letters, (20020213), vol. 512, no. 1-3, pages 275 - 281, XP004341393
OPPOSITION- PUFFER et al., "Differential Roles of Developmentally Distinct SNAP-25 Isoforms in the Neurotransmitter Release Process", Biochemistry, (20010000), vol. 40, pages 9374 - 9378, XP055447768
OPPOSITION- Borden Lacy, et al., "Crystal structure of botulinum neurotoxin type A and implications for toxicity", Nat. Struct. Biol., (19980000), vol. 5, no. 10, pages 898 - 902, XP055090018
OPPOSITION- SWAMINATHAN et al., "Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B", Nat. Struct. Biol., (20000801), vol. 7, pages 693 - 699, XP055053165
OPPOSITION- HAMILTON et al., "Do astrocytes really exocytose neurotransmitters", Nature Reviews, Neuroscience, (20100400), vol. 11, pages 227 - 238, XP055447793
OPPOSITION- UMLAND TC, "Structure of the receptor binding f ragment He of tetanus neurotoxin", Nat. Struct. Biol., (19971000), vol. 4, no. 10, pages 788 - 792, XP001010535
OPPOSITION- HERREROS J, "C-terminal half of tetanus toxin fragment C is sufficient for neuronal binding and interaction with a putative protein receptor", Biochem. J., (20000400), vol. 347, no. 1, pages 199 - 204, XP001010346
OPPOSITION- RUMMEL A, "The Hcc-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction", Mol. Microbiol., (20040200), vol. 51, no. 3, pages 631 - 643, XP002363868
OPPOSITION- RUMMEL A, "Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept", PNAS, (20070102), vol. 104, no. 1, pages 359 - 364, XP055069704
OPPOSITION- SCHIAVO et al., "Botulinum Neurotoxin Type C Cleaves a Single Lys-Ala Bond within the Carboxyl-terminal Region of Syntaxins", J Biol Chem, (19950505), vol. 270, no. 18, pages 10566 - 10570, XP055357456
OPPOSITION- FORAN et al., "Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons", J Biol Chem, (20030110), vol. 278, no. 2, pages 1363 - 1371, XP002364068
OPPOSITION- SUDHOF et al., "Membrane Fusion: Grappling with SNARE and SM Proteins", Science , Review, (20090123), vol. 323, no. 5913, pages 474 - 477, XP055447805
OPPOSITION- WANG et al., "Oxygen Sensing and Osteogenesis", Ann. New York Acad Sciences, (20070000), vol. 1117, pages 1 - 11, XP055447817
OPPOSITION- HAWI et al., "DNA Variation in the SNAP25 Gene Confers Risk to ADHD and Is Associated with Reduced Expression in Prefrontal Cortex", PLOS One, (20130412), vol. 8, no. 4, pages 1 - 8, XP055447763
OPPOSITION- PALMA Carla, "Tachykinins and their receptors in human malignancies", Current Drug Targets, (20060800), vol. 7, no. 8, pages 1043 - 1052, XP009122033
OPPOSITION- REDDY et al., "Neurokinin receptors as potential targets in breast cancer treatment", Current Drug Discovery Technologies, (20080000), vol. 5, no. 1, pages 15 - 19, XP009145163

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents